Issue 6, 2011

A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action

Abstract

Clostridium botulinum produces the most lethal toxins known to man, as such they are high risk terrorist threats, and alarmingly there is no approved therapeutic. We report the first cross-over small molecule inhibitor of these neurotoxins and propose a mechanism by which it may impart its inhibitory activity.

Graphical abstract: A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action

Supplementary files

Article information

Article type
Communication
Submitted
26 Sep 2010
Accepted
06 Dec 2010
First published
04 Jan 2011

Chem. Commun., 2011,47, 1713-1715

A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action

N. T. Salzameda, L. M. Eubanks, J. S. Zakhari, K. Tsuchikama, N. J. DeNunzio, K. N. Allen, M. S. Hixon and K. D. Janda, Chem. Commun., 2011, 47, 1713 DOI: 10.1039/C0CC04078A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements